Acutus Medical and Biotronik announced an alliance to collaborate on electrophysiology, mapping, ablation and accessory products across select markets.
The products involved in the collaboration center around the treatment of cardiac arrhythmias in markets that include Europe and Asia, according to a news release.
Acutus’ AcQMap system with SuperMap multi-mode mapping capabilities lies in the center of the new alliance between companies, as Acutus touts it as the only commercially available non-contact mapping system that can map stable and unstable rhythms. Those capabilities allow for electrophysiologists to see changes in conduction during a procedure, giving them a basis on which to customize therapy.
Under the agreement, Acutus expects to, under a private label, market a range of Biotronik EP ablation catheters and diagnostic/accessory products to most international markets with the goal to optimize care for arrhythmia patients with digitally-linked devices and monitors.
With Biotronik’s Home Monitoring network and Acutus’ system, the companies believe they can create a secure digital network across cardiac rhythm management and electrophysiology mapping and ablation devices to optimize care.
“Healthcare systems around the world are facing continuous pressure to provide more targeted care for patients with better outcomes and reduced costs,” Acutus president & CEO Vince Burgess said in the news release. “We are at the forefront of equipping electrophysiologists with the technology they need to deliver advanced and individualized ablation therapy – more efficiently. We believe this international alliance has the potential to vault Acutus to the forefront of this important market.”
“As arrhythmias become more common, unprecedented access to real-time data will be integral to improving diagnosis and care,” added Biotronik segment head for EP & sensors Dr. Hans-Juergen Wildau. “We believe pairing BIOTRONIK’s cardiac monitoring portfolio with Acutus’ innovative mapping technology will give EP specialists the edge in therapy guidance systems.”